Decompressive Hemicraniectomy versus Intensive Medical Management in Patients with Malignant Middle Cerebral Artery Infarction
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 8
Abstract
ABSTRACT Introduction: Decompressive Hemicraniectomy (DHC) is a surgical technique which involves the removal of some part of skull to relieve the raised intracranial pressure, in setting of large cerebral mass effect. Some of the recent randomised clinical trials in western world have well established the role of ‘DHC’ in malignant Middle Cerebral Artery Infarction (mMCAI) to reduce death risk. However, Indian data regarding the same is scarce. Aim: The present study aimed to compare the outcomes of ‘DHC’ and best medical management in mMCAI. Materials and Methods: This study was a prospective, non-randomised intervention study conducted at the Neurology department of ‘Sri Venkateswara Institute of Medical Sciences’, Tirupati from November 2015 to October 2016. The study comprised of 60 patients having mMCAI out of which 20 underwent surgery and 40 received the best medical management alone. DHC was performed within 48 hours of the stroke onset. Both the groups were followed-up for six months and observed for difference in mortality and disability using modified Rankin Score (mRS). Good functional outcome was defined as mRS≤3. Split data analysis was performed for patients with age ≤60 and >60 years. Results: Cumulative death rate at the end of six months in medical and surgical group was 55% and 30% respectively, with a non-significant Absolute Risk Reduction (ARR) of 25% with surgery. Subgroup analysis revealed a significant mortality reduction at six months with surgery in patients with age ≤60 years (14% vs 68%, p=0.004). On the contrary, patients older than 60 years who underwent surgery had a non-significantly higher death rate at six months (67% vs 39%). Good functional outcome as defined by mRS≤3 at six months was more frequent in surgery group (6/20, 30%) as compared with medical management group (10/40, 25%). This difference was not statistically significant. Conclusion: DHC in mMCAI is life-saving in Indian patients with age ≤60 years, per contra, may increase the chances of death in patients older than 60 years.
Authors and Affiliations
Madhavarao Veeramalla, Bhuma Vengamma, Dusyanth Babu Jasti
Keywords
Related Articles
- EP ID EP524744
- DOI 10.7860/JCDR/2018/35498.11931
- Views 58
- Downloads 0
Primary Squamous Cell Carcinoma of the Excretory Duct of the Submandibular Gland: A Rare Case
ABSTRACT Primary Squamous Cell Carcinoma (SCC) of the salivary glands is a very rare disease and establishing the true origin of an SCC manifesting in a salivary gland is always a daunting task, due to the natural proxim...
Insulinoma: A Diagnostic Challenge!
ABSTRACT Insulinoma is a common tumour arising from islets of Langerhans. Patients with insulinomas present with neuroglycopenic symptoms such as repeated episodes of headache, blurred vision, diplopia and lethargy espec...
Tuberculosis Vaccine Development: Current Status and Future Directions
Editorial
Pleomorphic Adenoma Masquerading as Odontogenic Lesion in the Maxilla
Images in Medicine
Fungal Pericarditis due to Aspergillus nidulans: A Rare Case Report
ABSTRACT Disseminated Aspergillosis though rare is usually seen among immunocompromised and neutropenic patients. Aspergillus spp are usually considered to be a laboratory contaminants until its association with the dise...